SecBot SecBot
8-K ·Filed Jun 18, 2026

MPLT

MapLight Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed4mo ago SEC0001193125-26-276065
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine personnel change with no financial or operational implications. The market should not read into this as a sign of financial distress. Monitor for any future 10-Q filing for the separation agreement exhibit, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
MPLT ▼ -59.45% at T+60d
NEUTRAL call -59.45% · α vs SPY -61.20% · entry $29.79 → $12.08
Entry = T+0 close
Jun 18, 2026
via day close
T+1d
-3.86%
call -3.86% · α -2.41%
$28.64
settled 4mo ago
T+5d
+11.72%
call +11.72% · α +13.78%
$33.28
settled 4mo ago
T+20d
+27.12%
call +27.12% · α +27.27%
$37.87
settled 3mo ago
T+60d
-59.45%
call -59.45% · α -61.20%
$12.08
settled 6w ago

Price Chart

Loading chart...

Executive Summary

MapLight Therapeutics CFO Vishwas Setia was separated effective immediately due to an HR violation, with no severance. The company's Chief Administrative and Accounting Officer, Jonathan Gillis, was appointed as interim CFO. The separation is explicitly stated as unrelated to financial or operating results.

Key Facts

  • CFO Vishwas Setia separated effective June 18, 2026, following a human resources violation
  • Separation is explicitly unrelated to financial or operating results, internal controls, or clinical programs
  • No severance payment is entitled
  • Interim CFO Jonathan Gillis appointed, who also serves as Chief Administrative and Accounting Officer
  • COBRA health coverage continued for up to three months

Financial Impact

No financial impact specified in the filing; no severance payment.

Risk Factors

  • Potential distraction from interim CFO transition
  • No material risk to operations or financial reporting

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-276065
Document: 0001193125-26-276065-index-headers.html0001193125-26-276065
Document: 0001193125-26-276065-index.html0001193125-26-276065
Document: 0001193125-26-276065.txt0001193125-26-276065
31 reports for MPLT
Performance horizon
67% Hit rate @ T+20 4 of 6 directional calls Went positive at some point 6 of 7 best @ T+60▲ +57.24%May 18, 2026
Filters
Rows
Reports for MPLT — sortable, filterable
TypeNow
Oct 16, 2026
10d ago
Insider Cluster
BEARISH ★ 4/10
$8.00awaiting T+20—$7.66 (+4.25%)
Oct 15, 2026
11d ago
144
NEUTRAL ★ 2/10
$7.70awaiting T+20—$7.66 (−0.52%)
Oct 15, 2026
11d ago
144
NEUTRAL ★ 2/10
$7.70awaiting T+20—$7.66 (−0.52%)
Oct 15, 2026
11d ago
144
NEUTRAL ★ 2/10
$7.70awaiting T+20—$7.66 (−0.52%)
Sep 24, 2026
4w ago
EFFECT
NEUTRAL ★ 4/10
$10.76 $8.25▼ −23.33%▼ −22.91%$7.66 (−28.81%)
Sep 18, 2026
5w ago
S-1/A
NEUTRAL ★ 4/10
$10.90 $8.00▼ −26.61%▼ −25.70%$7.66 (−29.72%)
Aug 4, 2026
11w ago
Insider Cluster
BULLISH ★ 7/10
$12.92 $13.06▲ +1.08%▲ +1.69%$7.66 (−40.71%)
Aug 3, 2026
12w ago
144
NEUTRAL ★ 2/10
$12.94 $13.31▲ +2.86%▲ +4.10%$7.66 (−40.80%)
Jul 30, 2026
12w ago
144
BEARISH ★ 5/10
$13.02 $12.60▲ +3.23%▲ +6.21%$7.66 (+41.17%)
Jul 28, 2026
12w ago
Insider Buy
NEUTRAL ★ 3/10
$15.02 $12.86▼ −14.38%▼ −19.40%$7.66 (−49.00%)
Showing 10 of 31

US Market Status

Market Closed — Opens in 4h 12m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 18, 2026